naphazoline has been researched along with Diffuse Parenchymal Lung Disease in 1 studies
Naphazoline: An adrenergic vasoconstrictor agent used as a decongestant.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carbone, RG | 1 |
| Monselise, A | 1 |
| Puppo, F | 1 |
1 other study available for naphazoline and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
Treprostinil and Clinical Outcome in Pulmonary Hypertension and Interstitial Lung Disease: Is All Clear?
Topics: Antihypertensive Agents; Epoprostenol; Humans; Hypertension, Pulmonary; Lung Diseases, Interstitial; | 2023 |